Serimmune Inc.
Biotechnology company · Goleta, California, United States
Serimmune Inc. is a biotechnology company headquartered in Goleta, California, United States. Its earliest recorded incorporation is in 2014. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2023.
Serimmune at a glance
What does Serimmune do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $2.9 million in total (2016 to 2019). NIH funding came from the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $11.5 million sold (2023).
Frequently asked questions about Serimmune
Where is Serimmune headquartered?
Serimmune Inc. is headquartered in Goleta, California, United States.
What does Serimmune do?
Serimmune Inc. is a biotechnology company.
When was Serimmune founded?
The earliest incorporation on record for Serimmune Inc. is in 2014, according to public company registers.
Similar companies
- TrueVision Systems IncGoleta, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences